Carbohydrate-based vaccine adjuvants - discovery and development

Area of Science:

• Vaccinology
• Immunology
• Carbohydrate Chemistry

Background:

• Adjuvants are crucial for enhancing vaccine-induced adaptive immune responses.
• There is a critical need for novel, potent, and safe adjuvants for human vaccine development.
• Carbohydrate molecules offer high biocompatibility and in vivo tolerability, making them promising adjuvant candidates.

Purpose of the Study:

• To review promising carbohydrate-based adjuvants for human vaccines.
• To discuss the current status, applications, and development strategies of specific carbohydrate adjuvants.
• To provide insights into the future prospects of carbohydrate-based adjuvant research.

Main Methods:

• Review of preclinical and clinical studies on selected carbohydrate-based adjuvants.
• Analysis of adjuvant formulation systems.
• Discussion of development strategies for novel adjuvants.

Main Results:

• Lipopolysaccharide, trehalose-6,6'-dibehenate, QS-21, and inulin are identified as promising carbohydrate-based adjuvants.
• Carbohydrate adjuvants demonstrate potential as alternatives to Alum salts.
• Combining multiple adjuvants in formulations is an effective development strategy.

Conclusions:

• Carbohydrate-based adjuvants represent a promising alternative to Alum salts for human vaccines.
• Further research is essential to develop novel adjuvant systems with enhanced stability, potency, and safety.
• Advancements in synthetic carbohydrate chemistry can significantly aid the study and development of carbohydrate-based adjuvants.